arrow
H

Hikmat Abdel-Razeq

section of hematology and medical oncology
H指数:21
被引数:2,094

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Global Disparities and Trends in Radiotherapy for Early-Stage Glottic Cancer

全球早期声门癌放射治疗的差异与趋势

2026-04-300
OAAI
Adenoid cystic carcinoma of the breast with aggressive behavior: A case report and review of the literature

Lataifeh, H.; Abuhijla, F.; Wahbeh, L.; Abuhijlih, R.; Asha, W.; Alzibdeh, A.; Jaber, O.; Mohamad, I.; Abdel-Razeq, H. 乳腺腺样囊性癌具有侵袭性行为:病例报告及文献综述。Oncol. Lett. 2025, 30, 510. [Google Scholar] [CrossRef]

2025-11-011
PRE
Comparative Evaluation of Risk Assessment Models for Predicting Venous Thromboembolic Events in Cancer Patients with Implanted Central Venous Access Devices

癌症患者植入中心静脉导管预测静脉血栓栓塞事件的模型风险评估比较评价

2025-10-140
OAAI
Enhancing Early Detection of Pancreatic Cancer in Genetically Predisposed Individuals: Integrating Advanced Imaging Modalities with Emerging Biomarkers and Liquid Biopsy

增强遗传易感个体胰腺癌的早期检测:整合先进影像学方法与新兴生物标志物及液体活检

2025-08-300
OA
Lung Cancer in Jordan

约旦肺癌

2025-08-040
PRE
Bridging borders for resilience in cancer control in the Middle East: a strategic alliance of Saudi Arabia, Qatar, and Jordan

为中东癌症控制建立韧性:沙特阿拉伯、卡塔尔和约旦的战略联盟

2025-06-110
PRE
Transforming cancer care in Jordan: a 10-year comprehensive patient-centred strategy guided by local experts

转变约旦癌症护理:一项由当地专家指导的为期10年的综合性以患者为中心的战略

2025-06-110
PRE
Dual Anti-HER2 Therapy Vs Trastuzumab Alone with Neoadjuvant Anthracycline and Taxane in HER2-Positive Early-Stage Breast Cancer: Real-World Insights

双HER2靶向治疗与单独使用曲妥珠单抗联合新辅助蒽环类和紫杉类药物在HER2阳性早期乳腺癌中的疗效比较:真实世界研究洞察

2025-03-050
OA
Outcomes of Peripheral Blood Haploidentical Stem Cell Transplantation With Post-Transplant Cyclophosphamide and Earlier Initiation of Immunosuppression

异基因外周血造血干细胞移植术后使用环磷酰胺并早期启动免疫抑制治疗的结局

2025-02-010
PRE
Patient Characteristics and Treatment Outcomes of TP53 Mutated Myeloid Neoplasms : A Single Cancer Center Experience from the MENA Region

TP53突变髓系肿瘤患者的特征及治疗结局:来自MENA地区单一癌症中心的经验

BLOOD
IF23.1
2024-11-050
PRE